Does anti-tumour necrosis factor alpha therapy exert a long-term structural benefit in hand osteoarthritis?

Jorge A. Roman-Blas; Helen Keen; Gabriel Herrero-Beaumont

doi:10.1093/rheumatology/key210

Does anti-tumour necrosis factor alpha therapy exert a long-term structural benefit in hand osteoarthritis?

Jorge A. Roman-Blas
, Helen Keen
, Gabriel Herrero-Beaumont

UWA Medical School

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1879-1880
Number of pages	2
Journal	Rheumatology (Oxford, England)
Volume	57
Issue number	11
DOIs	https://doi.org/10.1093/rheumatology/key210
Publication status	Published - 1 Nov 2018

Access to Document

10.1093/rheumatology/key210

Cite this

@article{1856384ae5c1491ea709936a9b436655,

title = "Does anti-tumour necrosis factor alpha therapy exert a long-term structural benefit in hand osteoarthritis?",

author = "Roman-Blas, \{Jorge A.\} and Helen Keen and Gabriel Herrero-Beaumont",

year = "2018",

month = nov,

day = "1",

doi = "10.1093/rheumatology/key210",

language = "English",

volume = "57",

pages = "1879--1880",

journal = "Rheumatology (Oxford, England)",

issn = "1462-0324",